T 1047/17 (TREATMENT OF INTERSTITIAL CYSTITIS WITH HIGH DOSE CHONDROITIN SULFATE/Aralez Pharmaceuticals Canada Inc.) of 17.12.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T104717.20191217
- Date of decision
- 17 December 2019
- Case number
- T 1047/17
- Online on
- 5 March 2020
- Petition for review of
- -
- Application number
- 04711966.4
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- TREATMENT OF INTERSTITIAL CYSTITIS WITH HIGH DOSE CHONDROITIN SULFATE
- Applicant name
- Aralez Pharmaceuticals Canada Inc.
- Opponent name
- Farco-Pharma GmbH
IBSA Institut Biochimique SA - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- Rules of procedure of the Boards of Appeal Art 12Rules of procedure of the Boards of Appeal Art 13European Patent Convention Art 54European Patent Convention Art 56
- Keywords
- Admission of documents (yes)
Admission of requests (yes)
Main request - Novelty (Yes)
All requests - Inventive step (No) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.